Conference
Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy.
Abstract
667
Background: Recent research suggested that patients (pts) with small renal masses (4cm or less) were at low risk of disease recurrence after surgery. The impact of tumor size on survival in mRCC patients treated with targeted therapy (TKI) is unclear. Methods: Two cohorts were identified from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Cohort 1 pts had initial nephrectomy for M0 RCC and …
Authors
Xie W; DiNatale R; Hakimi AA; Donskov F; Porta C; Reaume MN; Basappa NS; Hansen AR; Rini BI; Beuselinck B
Volume
36
Pagination
pp. 667-667
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2018
DOI
10.1200/jco.2018.36.6_suppl.667
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X